Family Reach is a financial lifeline for families fighting cancer.
Family Reach is a financial lifeline for families fighting cancer.
Family Reach is a national nonprofit dedicated to alleviating the financial burden of cancer. Working with more than 400 top-tier hospitals and cancer centers nationwide, we provide immediate financial assistance, education and navigation to families before they hit critical breaking points. Our efficient, solutions-driven model bridges the gap between hospital and home, quickly providing the vital support families need to stay afloat.
The Problem
1 out of 3 Americans will experience cancer in their lifetime
Nearly ⅓ of families are unable to meet their basic needs because their child is in cancer treatment
Cancer patients are 2.65 times more likely to declare bankruptcy than those without cancer
Cancer patients who file for bankruptcy have a 79% greater risk of early mortality
The Solution
The Financial Treatment Initiative
Education & Awareness
We empower cancer patients and caregivers through a Financial Handbook that prepares them for financial roadblocks. We also focus on data collection and program evaluation to expand awareness beyond the healthcare industry.
Learn more.
Financial Navigation
To lower out-of-pocket healthcare costs, Financial Navigators work alongside patients and their oncology care team to maximize insurance coverage and apply for co-pay and prescription assistance.
Learn more.
Financial Planning
Certified Financial Planners™ help manage spending, negotiate reductions in debt and maintain a healthy financial situation as families juggle lost income and increased expenses during cancer treatment.
Learn more.
Financial Assistance
Families fighting cancer often find themselves unable to make ends meet. Daily living expenses like mortgage, utilities, gas and groceries are covered through financial assistance, so patients and caregivers can remain financially stable during treatment.
Learn more.
Click here to learn more about our innovative approach to solving cancer-related financial toxicity.
